GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Other Financing

Chordia Therapeutics (TSE:190A) Other Financing : 円0.00 Mil (TTM As of Aug. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Other Financing?

Chordia Therapeutics's Other Financing for the six months ended in Aug. 2024 was 円0.00 Mil.

Chordia Therapeutics's Other Financing for the trailing twelve months (TTM) ended in Aug. 2024 was 円0.00 Mil.


Chordia Therapeutics Other Financing Historical Data

The historical data trend for Chordia Therapeutics's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Other Financing Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Other Financing
- - - -

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Aug24
Other Financing - - - -

Chordia Therapeutics Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in Aug. 2024 was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordia Therapeutics Other Financing Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines